QualTek Molecular Laboratories - Now Part of Discovery Life Sciences

QualTek is now part of Discovery Life Sciences (Discovery). Discovery's services help scientists discover, develop, and validate IHC biomarkers for use in preclinical, translational, companion diagnostic and clinical trial programs via a uniquely powerful suite of solutions.QualTek’s expertise and scale augment Discovery’s leading biospecimen, flow cytometry, and genomic services to deliver meaningful answers that clients can trust to develop innovative drugs and diagnostics faster and more cost-effectively.QualTek was founded 22 years ago to provide expert immunohistochemistry (IHC) services to pharmaceutical and biotechnology companies. During this time QualTek has worked on over 1,700 projects covering a broad spectrum of research and clinical studies. QualTek scientists are truly experts and pioneers in the field of IHC and its vast applications. The founders of QualTek previously developed instruments to automate IHC and integrated hundreds of diagnostic tests on their platforms. Our background and understanding of research and clinical applications of IHC allows us to integrate data generated from IHC into various stages of the dynamic drug development process from basic research through to testing of clinical samples and development of companion diagnostics. QualTek has two GLP capable laboratory locations in Newtown, PA and Santa Barbara, CA. In addition, our CA laboratory is CAP/CLIA certified.